Adacel Polio

Adacel Polio

Manufacturer:

sanofi pasteur

Distributor:

DKSH
Concise Prescribing Info
Contents
Per 0.5 mL Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, acellular pertussis [pertussis toxoid (PT) 2.5 mcg, filamentous haemagglutinin (FHA) 5 mcg, pertactin (PRN) 3 mcg, fimbriae types 2 & 3 (FIM) 5 mcg], inactivated poliomyelitis vaccine [type 1 (Mahoney) 40 D-antigen u, type 2 (MEF-1) 8 D-antigen u, type 3 (Saukett) 32 D-antigen u]
Indications/Uses
Active booster immunization for the prevention of tetanus, diphtheria, pertussis & poliomyelitis in persons ≥4 yr. May be considered as an alternative for the 5th dose of diphtheria, tetanus, acellular pertussis & inactivated poliomyelitis vaccine (DTaP-IPV) in childn 4-6 yr. Tetanus prophylaxis in wound management.
Dosage/Direction for Use
Contraindications
Hypersensitivity. Encephalopathy (eg, coma, decreased consciousness level, prolonged seizures) w/in 7 days of a previous dose of a pertussis-containing vaccine not attributable to another identifiable cause.
Special Precautions
Not for treatment of Bordetella pertussis, Corynebacterium diphtheriae, Clostridium tetani or poliomyelitis infections. Do not administer intravascularly, intradermally, SC, or into the buttocks. Risk of syncope following vaccination. May not protect 100% of vaccinated persons. Postpone vaccination in case of an acute or febrile disease. Possible inj site hematoma in persons w/ any bleeding disorders (eg, haemophilia or thrombocytopenia, or in persons on anticoagulant therapy). Evaluate persons sensitive to the vaccine components for possibility of allergic reactions. Consider delaying of vaccination until completion of any immunosuppressive treatment. Not to be administered to individuals w/ progressive neurological disorder, uncontrolled epilepsy, or progressive encephalopathy until a treatment regimen has been established & condition has stabilized. Guillain-Barré syndrome that has occurred w/in 6 wk of receipt of prior vaccine containing tetanus toxoid. Pregnancy & lactation.
Adverse Reactions
Pain, swelling, redness; fever, headache, nausea, diarrhea, vomiting, body ache, sore or swollen joints, tiredness, chills, rash.
Drug Interactions
Development of the expected immune response may be interfered by immunosuppressive treatments.
ATC Classification
J07CA02 - diphtheria-pertussis-poliomyelitis-tetanus ; Belongs to the class of combined bacterial and viral vaccines.
Presentation/Packing
Form
Adacel Polio susp for inj
Packing/Price
((w/ 2 separate needles)) 0.5 mL x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in